Valuation: Camlin Fine Sciences Limited

Market Cap 2.62TCr 28Cr 24Cr 22Cr 21Cr 39Cr 40Cr 269.71Cr 104.36Cr 1.29TCr 104.26Cr 101.98Cr 4.49TCr P/E 2026
67.3x
P/E 2027 * 34.1x
Enterprise Value 2.62TCr 28Cr 24Cr 22Cr 21Cr 39Cr 40Cr 269.71Cr 104.36Cr 1.29TCr 104.26Cr 101.98Cr 4.49TCr EV / Sales 2026
1.08x
EV / Sales 2027 * 1.23x
Free-Float
55.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.48%
1 week-2.75%
Current month+11.58%
1 month+12.31%
3 months+21.31%
6 months-8.83%
Current year-8.09%
1 week 134.5
Extreme 134.5
143.5
1 month 113.55
Extreme 113.55
146.7
Current year 96.3
Extreme 96.3
192
1 year 96.3
Extreme 96.3
328.6
3 years 80
Extreme 80
334.7
5 years 80
Extreme 80
334.7
10 years 33.4
Extreme 33.4
334.7
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Executive Officer 60 01/06/2021
Director of Finance/CFO - 10/02/2017
Director TitleAgeSince
Director/Board Member 60 04/08/2014
Chairman 63 17/06/2021
Director/Board Member 60 13/10/2017
Date Insider Type Main position Quantity % Market Cap.
09/24/09
Infinity Holdings
SellCompany 13,38,600 0.7992%
09/24/09
Infinity Holdings
SellCompany 6,63,586 0.3962%
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%-2.75%-58.30%-18.21% 28Cr
+0.87%+5.40%+7.75%+57.23% 7.98TCr
+0.03%+4.34%-12.53%+14.40% 3.87TCr
-0.24%+2.41%-22.23%-31.11% 3.33TCr
+0.67%+1.57%+9.81%+20.67% 2.54TCr
-2.08%-10.16%+103.09%+0.41% 2.04TCr
-1.76%-1.62%+18.17%+5.03% 2.02TCr
-0.42%-4.13%-33.98%-32.54% 1.85TCr
-5.21%-16.62%+109.73%-40.64% 1.58TCr
-0.32%+2.94%-6.51%-6.15% 1.39TCr
Average -0.61%-1.47%+11.50%-3.09% 2.66TCr
Weighted average by Cap. -0.12%+0.82%+11.69%+12.74%

Financials

2026 2027 *
Net sales 1.79TCr 19Cr 17Cr 15Cr 14Cr 27Cr 28Cr 184.52Cr 71Cr 885.6Cr 71Cr 70Cr 3.07TCr 2.13TCr 23Cr 20Cr 18Cr 17Cr 32Cr 33Cr 219.66Cr 85Cr 1.05TCr 85Cr 83Cr 3.66TCr
Net income 40L 42.4T 37.18T 34.27T 32.08T 60.16T 61.41T 4L 2L 19.77L 2L 2L 68.55L 76Cr 81.1L 71.11L 65.54L 61.36L 1.15Cr 1.17Cr 7.88Cr 3.05Cr 38Cr 3.05Cr 2.98Cr 131.1Cr
Net Debt - -
Logo Camlin Fine Sciences Limited
Camlin Fine Sciences Limited is an India-based specialty chemicals company, which is engaged in the research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company's products portfolio is categorized into shelf-life solutions, performance chemicals, aroma ingredients, and health and wellness. Its products include catechol, tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Ascorbyl Palmitate (ASP), 4-Tertiary Butyl Catechol, Xtendra, Guaiacol, Para DiMethoxy Benzene, NaSure, Hydroquinone, and Veratrole. Its aroma ingredients mainly include Vanillin, Ethyl Vanillin, and Natural Vanillin. The Company's products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care. Its brands include Ezential, Nasure, adorr, Dinamics, Xtendra, and Biosus.
Employees
661
Date Price Change Volume
25/26/25 ₹136.35 -1.48% 29,505
24/26/24 ₹138.40 +0.40% 37,053
23/26/23 ₹137.85 -2.03% 55,019
22/26/22 ₹140.70 +0.36% 99,137
19/26/19 ₹140.20 +2.07% 1,27,844
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
136.35INR
Average target price
177.50INR
Spread / Average Target
+30.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMLINFINE Stock